Does the kidney injury molecule-1 predict cisplatin-induced kidney injury in early stage?

Annals of Clinical Biochemistry

Volumn 52, Issue 1, 2015, Pages 88-94

  Tekce, Buket Kin ^a   Uyeturk, Ummugul ^a   Tekce, Hikmet ^a   Uyeturk, Ugur ^a   Aktas, Gulali ^a   Akkaya, Akcan ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

acute kidney injury; biomarker; cisplatin; Kidney injury molecule 1

Indexed keywords

CISPLATIN; KIDNEY INJURY MOLECULE 1; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HUMAN; KIDNEY INJURY; MALE; NON SMALL CELL LUNG CANCER; PREDICTIVE VALUE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; ACUTE KIDNEY INJURY; AGED; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; EARLY DIAGNOSIS; KIDNEY; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; STOMACH NEOPLASMS; URINE;

ACUTE KIDNEY INJURY; ADULT; AGED; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; CISPLATIN; EARLY DIAGNOSIS; FEMALE; HUMANS; KIDNEY; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTORS, VIRUS; ROC CURVE; STOMACH NEOPLASMS;

EID: 84918775812     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214528312     Document Type: Article

References (29)

1. Wang D,Lippard SJ.Cellular processing of platinum anticancer drugs.Nat Rev Drug Discov. 2005;4:307-320
2. Arany I,Safirstein RL.Cisplatin nephrotoxicity.Semin Nephrol. 2003;23:460-464
3. Cohen SM,Lippard SJ.Cisplatin: from DNA damage to cancer chemotherapy.Prog Nucleic Acid Res Mol Biol. 2001;67:93-130
4. Siddik ZH.Cisplatin: mode of cytotoxic action and molecular basis of resistance.Oncogene. 2003;22:7265-7279
5. Pabla N,Dong Z.Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.Kidney Int. 2008;73:994-1007
6. Launay-Vacher V,Rey JB,Isnard-Bagnis C, et al.Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care.Cancer Chemother Pharmacol. 2008;61:903-909
7. Chung KK,Stewart IJ,Gisler C, et al.The Acute Kidney Injury Network (AKIN) criteria applied in burns.J Burn Care Res. 2012;33:483-490
8. Mehta RL,Chertow GM.Acute renal failure definitions and classification: time for change?.J Am Soc Nephrol. 2003;14:2178-2187
9. Lin HYH,Lee SC,Lin SF, et al.Urinary neutrophil gelatinase-associated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels.Kaohsiung J Med Sci. 2013;29:304-311
10. Ichimura T,Bonventre JV,Bailly V, et al.Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury.J Biol Chem. 1998;273:4135-4142
11. Ichimura T,Hung CC,Yang SA, et al.Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.Am J Physiol Renal Physiol. 2004;286:F552-F563
12. Zhou Y,Vaidya VS,Brown RP, et al.Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.Toxicol Sci. 2008;101:159-170
13. Jin ZK,Tian PX,Wang XZ, et al.Kidney injury molecule-1 and osteopontin: new markers for prediction of early kidney transplant rejection.Mol Immunol. 2013;54:457-464
14. Levey AS,Bosch JP,Lewis JB, et al.A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group.Ann Intern Med. 1999;130:461-470
15. Lamb E.Assessment of kidney function in adults.Medicine. 2011;39:306-311
16. Poste G.Biospecimens, biomarkers, and burgeoning data: the imperative for more rigorous research standards.Trends Mol Med. 2012;18:717-722
17. Mehta RL,Kellum JA,Shah SV, et al.Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury.Crit Care. 2007;11:R31-R31
18. Lewington AJP,Sayed A.Acute kidney injury: how do we define it?.Ann Clin Biochem. 2010;47:4-7
19. Ajani JA,Bentrem DJ,Besh S, et al.Gastric cancer, version 2.2013: featured updates to the NCCN guidelines.J Natl Compr Cancer Netw. 2013;11:531-546
20. Ettinger DS,Akerley W,Borghaei H, et al.Non-small cell lung cancer, version 2.2013 featured updates to the NCCN guidelines.J Natl Compr Cancer Netw. 2013;11:645-653
21. Yao X,Panichpisal K,Kurtzman N, et al.Cisplatin nephrotoxicity: a review.Am J Med Sci. 2007;334:115-124
22. Star RA.Treatment of acute renal failure.Kidney Int. 1998;54:1817-1831
23. Han WK,Bailly V,Abichandani R, et al.Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.Kidney Int. 2002;62:237-244
24. Zhang PL,Rothblum LI,Han WK, et al.Kidney injury molecule-1 expression in transplant biopsies is a sensitive measure of cell injury.Kidney Int. 2008;73:608-614
25. Przybylowski P,Malyszko J,Kozlowska S, et al.Kidney injury molecule-1 correlates with kidney function in heart allograft recipients.Transpl Proc. 2011;43:3061-3063
26. Liang XL,Liu SX,Chen YH, et al.Combination of urinary kidney injury molecule-1 and interleukin-18 as early biomarker for the diagnosis and progressive assessment of acute kidney injury following cardiopulmonary bypass surgery: a prospective nested case-control study.Biomarkers. 2010;15:332-339
27. Seo MS,Park MY,Choi SJ, et al.Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy.BMC Nephrol. 2013;14:139-139
28. Lisowska-Myjak B.Serum and urinary biomarkers of acute kidney injury.Blood Purif. 2010;29:357-365
29. Vaidya VS,Ramirez V,Ichimura T, et al.Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury.Am J Physiol Renal Physiol. 2006;290:F517-F529